Literature DB >> 15246191

Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung.

Fauzia Siddiq1, Fazlul H Sarkar, Anil Wali, Harvey Ira Pass, Fulvio Lonardo.   

Abstract

Chemical transformation of the SV-40 immortalized bronchial epithelial cell line BEAS2-B induces alterations in molecules involved in cell cycle control, including up-regulation of EGFR and cyclin E [Oncogene 13 (1996) 1983; Clin Cancer Res 8 (2002) 54]. The finding that these changes also occur in vivo, in both pre-invasive and invasive lung cancer [Cancer Res 55 (1995) 1365; Cancer Res 59 (1999) 2470], proves this to be a suitable model to study lung carcinogenesis. The current study tested the hypothesis that chemical treatment of BEAS2-B with Cigarette Smoke Condensate (CSC) may affect levels of gene products involved in cell adhesion and tissue remodeling. To this end, we studied the extent of changes in osteonectin (ON) protein levels induced in BEAS 2 B-cells by CSC treatment and its timing to changes occurring in the anchorage independent cloning efficiency. ON, a multimodular protein component of the extra-cellular matrix, has been implicated in tissue remodeling occurring in neoplastic and non-neoplastic conditions, but its role in lung carcinogenesis is incompletely characterized. To validate the in vitro findings, as in our previous reports, we studied resected lung tissue, to assess whether ON expression in neoplastic lung tissue differs from normal, and to determine its cellular localization. We found that CSC treatment of BEAS2-B cells results in a 7-16-fold increase in ON protein levels, that is associated with increased colony forming efficiency. ON is absent in normal lung; in contrast it is present in the majority (39/52) of non-small cell lung cancer (NSCLC). Here, its expression is restricted to peritumoral fibroblasts in squamous cell carcinoma and adenocarcinoma. In contrast, it is localized to tumor cells in pulmonary sarcomatoid carcinoma (8/10). Thus, up-regulated ON is linked in vitro to cell transformation and in vivo, it is frequently expressed in tumor-associated fibrosis, compatible with its proposed role in tissue remodelling. Increased ON expression by tumor cells appears to represent a marker of sarcomatoid NSCLC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246191     DOI: 10.1016/j.lungcan.2004.01.020

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

1.  KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.

Authors:  Yanbin Zhou; Wayne L Hofstetter; Yong He; Wenxian Hu; Abujiang Pataer; Li Wang; Ji Wang; Yihong Zhou; Liping Yu; Bingliang Fang; Stephen G Swisher
Journal:  Cancer Biol Ther       Date:  2010-04-01       Impact factor: 4.742

2.  Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma.

Authors:  Xiao-Yu Yang; Dong Zhang; Qi-Fei Zou; Fei Fan; Feng Shen
Journal:  Med Oncol       Date:  2013-06-22       Impact factor: 3.064

Review 3.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.

Authors:  Sharon L I Wong; Maria B Sukkar
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

4.  Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs.

Authors:  Mark A Pershouse; Aubrey M Smartt; Corbin Schwanke; Elizabeth A Putnam
Journal:  Genomics       Date:  2009-05-13       Impact factor: 5.736

5.  Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.

Authors:  Amy Frey; Ayman O Soubani; Abdulgadir K Adam; Shijie Sheng; Harvey I Pass; Fulvio Lonardo
Journal:  Histopathology       Date:  2009-03-20       Impact factor: 5.087

6.  Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer.

Authors:  Federico Pio Fabrizio; Angelo Sparaneo; Andrea Fontana; Tommaso Mazza; Paolo Graziano; Angela Pantalone; Paola Parente; Flavia Centra; Natalizia Orlando; Domenico Trombetta; Annamaria la Torre; Gian Maria Ferretti; Marco Taurchini; Concetta Martina Di Micco; Evaristo Maiello; Vito Michele Fazio; Antonio Rossi; Lucia Anna Muscarella
Journal:  Cells       Date:  2020-06-22       Impact factor: 6.600

7.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.